Apeiron Investment Group Ltd. is 10% Owner at ATAI Life Sciences N.V. (ATAI). They have made 15 open-market trades across 4 companies since 2022, most recently 2026-09-17.
CIK 0001845711
14 open-market purchases totalling $100.8M since 2022, against 1 sale. Across 8 scored buys the stock is down 7.5% at ninety days, and 3.9 points behind the S&P over the same stretch.
14 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ATAI | 53,412,414 | $392.6M |
| ENHA | 43,343,818 | $53.1M |
| SNSE | 2,485,923 | $34.6M |
| BNOX | 93,369,060 | $23.6M |
| ANRO | 674,658 | $14.8M |
| Total | $518.7M |
Shares reported on the most recent Form 4, priced at the 2026-09-21 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 7% | 8% | 13% |
| Avg Move | -9.4% | -16.9% | -7.5% |
| Alpha | -7.4% | -13.5% | -3.9% |
| Scored | 14 | 13 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENHA | BUY | 2026-09-17 | 2026-09-21 | $1.15 | $7.0M | -2.1% | — | — |
| ENHA | BUY | 2026-09-04 | 2026-09-09 | $1.59 | $286K | -14.1% | -24.9% | — |
| ENHA | BUY | 2026-09-02 | 2026-09-04 | $1.58 | $210K | -8.1% | -8.8% | — |
| ENHA | BUY | 2026-08-18 | 2026-08-20 | $1.66 | $2.9M | -10.7% | -17.1% | — |
| ENHA | BUY | 2026-08-17 | 2026-08-18 | $1.65 | $330K | -3.0% | -12.0% | — |
| ENHA | BUY | 2026-08-14 | 2026-08-17 | $1.97 | $296K | -3.6% | -13.3% | — |
| ATAI | BUY | 2025-08-14 | 2025-08-18 | $2.19 | $38.0M | +10.7% | +9.8% | -5.7% |
| ATAI | BUY | 2025-03-24 | 2025-03-24 | $1.40 | $2.5M | -20.8% | -8.4% | +21.7% |
| ATAI | BUY | 2025-02-14 | 2025-02-19 | $2.10 | $45.5M | -30.2% | -32.6% | -4.7% |
| BNOX | SELL | 2024-10-02 | 2024-10-07 | $0.30 | $135K | +0.6% | +3.3% | N/A |
| SNSE | BUY | 2023-02-23 | 2023-02-27 | $1.61 | $4K | -3.3% | -13.2% | -0.7% |
| ATAI | BUY | 2022-04-20 | 2022-05-03 | $5.02 | $1.4M | -17.8% | -15.6% | -19.9% |
| ATAI | BUY | 2022-04-18 | 2022-04-20 | $5.12 | $1.2M | -11.6% | -22.8% | -14.9% |
| ATAI | BUY | 2022-04-14 | 2022-04-18 | $5.19 | $26K | -14.3% | -24.0% | -18.6% |
| ATAI | BUY | 2022-04-08 | 2022-04-12 | $4.82 | $1.1M | -2.7% | -36.4% | -17.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.